AC Immune Reports Interim Safety Data From Phase 1b/2 ABATE Trial of ACI-24.060 in Down Syndrome

AC Immune12/10 13:00

AC Immune Stock Jumps 20% on Data for Parkinson's Disease Drug

Seeking Alpha11/15 03:51

S&P 500 Moves Lower; US Crude Oil Inventories Increase

Benzinga11/15 03:08

Sector Update: Health Care Stocks Lower Thursday Afternoon

MT Newswires11/15 02:53

Hillenbrand Posts Better-Than-Expected Earnings, Joins Beazer Homes, Tapestry, Walt Disney And Other Big Stocks Moving Higher On Thursday

Benzinga11/14 23:11

AC Immune Reports Positive Interim Results From Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson's Disease

GlobeNewswire11/14 20:00